Parsec Financial Management, Inc. Gilead Sciences, Inc. Transaction History

Parsec Financial Management, Inc.

$2.37 Billion
Q1 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $2.3 Million - $2.88 Million	-39,723 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $281,125 - $319,082	-4,333 Reduced 9.84%	39,723 $2.88 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $423,333 - $456,729	-6,254 Reduced 12.43%	44,056 $2.91 Million
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $880,138 - $961,676	-13,867 Reduced 21.61%	50,310 $3.46 Million
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $2.56 Million - $2.93 Million	-42,745 Reduced 39.98%	64,177 $4.15 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $2.41 Million - $2.74 Million	-42,462 Reduced 28.42%	106,922 $6.23 Million
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $1.65 Million - $2.07 Million	-26,500 Reduced 15.07%	149,384 $9.44 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $1.1 Million - $1.28 Million	-15,270 Reduced 7.99%	175,884 $13.5 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $1.33 Million - $1.7 Million	-21,220 Reduced 9.99%	191,154 $14.3 Million
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $977,416 - $1.08 Million	-15,862 Reduced 6.95%	212,374 $13.8 Million
Q3 2019 Oct 23, 2019	SELL	$62.51 - $69.0 $344,242 - $379,983	-5,507 Reduced 2.36%	228,236 $14.5 Million
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $6.92 Million - $7.76 Million	111,857 Added 91.77%	233,743 $0
Q1 2019 Apr 25, 2019	BUY	$62.53 - $70.05 $986,910 - $1.11 Million	15,783 Added 14.88%	121,886 $7.92 Million
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $605,400 - $790,000	10,000 Added 10.41%	106,103 $6.64 Million
Q3 2018 Oct 30, 2018	BUY	$71.28 - $78.92 $177,130 - $196,116	2,485 Added 2.65%	96,103 $7.42 Million
Q2 2018 Jul 26, 2018	BUY	$64.88 - $75.68 $91,610 - $106,860	1,412 Added 1.53%	93,618 $6.63 Million
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $50,988 - $62,160	700 Added 0.76%	92,206 $6.95 Million
Q4 2017 Jan 26, 2018	SELL	$71.15 - $83.52 $226,114 - $265,426	-3,178 Reduced 3.36%	91,506 $6.56 Million
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $6.83 Million - $8.09 Million	94,684	94,684 $7.67 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.3 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.8 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.19 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.81 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.65 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.

Account